⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14645380 | 0.83 | — | — | |
| SCHEMBL10956161 | 0.77 | — | — | |
| SCHEMBL6090956 | 0.74 | — | — | |
| SCHEMBL4516041 | 0.72 | — | — | |
| SCHEMBL6092034 | 0.67 | — | — | |
| SCHEMBL8977588 | 0.67 | — | — | |
| SCHEMBL2995 | 0.65 | — | — | |
| SCHEMBL8381239 | 0.61 | TSHR (0.47) | — | |
| SCHEMBL3820390 | 0.61 | — | — | |
| SCHEMBL1483243 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196936-A1 | POLYNUCLEOTIDE CANCER VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-10-12 | — | — | WO | claimed |
| WO-2023196935-A1 | POLYNUCLEOTIDE VACCINE FORMULATIONS AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-10-12 | — | — | WO | claimed |
| EP-4221739-A1 | POLYNUCLEOTIDE VACCINES AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-08-09 | — | — | EP | claimed |
| EP-2934910-A2 | RUBBER COMPOSITION COMPRISING CELLULOSE | Compagnie Générale des Etablissements Michelin (FR) | 2015-10-28 | — | — | EP | claimed |
| EP-2934909-A1 | RUBBER COMPOSITION COMPRISING CELLULOSE | Compagnie Générale des Etablissements Michelin (FR) | 2015-10-28 | — | — | EP | claimed |
| WO-2014096192-A2 | RUBBER COMPOSITION COMPRISING CELLULOSE | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2014-06-26 | — | — | WO | claimed |
| WO-2014096188-A1 | RUBBER COMPOSITION COMPRISING CELLULOSE | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2014-06-26 | — | — | WO | claimed |
| US-8344177-B2 | Albumin binding molecules and uses thereof | PHILOCHEM AG (CH) | 2013-01-01 | — | — | US | claimed |
| US-20100172844-A1 | ALBUMIN BINDING MOLECULES AND USES THEREOF | PHILOCHEM AG (CH) | 2010-07-08 | — | — | US | claimed |
| EP-2094647-A2 | ALBUMIN BINDING MOLECULES AND USES THEREOF | Philochem AG (CH) | 2009-09-02 | — | — | EP | claimed |
| WO-2008053360-A2 | ALBUMIN BINDING MOLECULES AND USES THEREOF | PHILOCHEM AG (CH) | 2008-05-08 | — | — | WO | claimed |
| CN-116916949-A | Polynucleotide vaccine and methods of use thereof | 伊穆农股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| WO-2023196936-A1 | POLYNUCLEOTIDE CANCER VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023196935-A1 | POLYNUCLEOTIDE VACCINE FORMULATIONS AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-10-12 | — | — | WO | disclosed |
| EP-4221739-A1 | POLYNUCLEOTIDE VACCINES AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-08-09 | — | — | EP | disclosed |
| EP-2094647-A2 | ALBUMIN BINDING MOLECULES AND USES THEREOF | Philochem AG (CH) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008053360-A2 | ALBUMIN BINDING MOLECULES AND USES THEREOF | PHILOCHEM AG (CH) | 2008-05-08 | — | — | WO | disclosed |
| US-7071168-B2 | Anti-cancer compounds and methods related thereto | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2006-07-04 | — | — | US | disclosed |
| US-6388054-B1 | AMINO ACID SEQUENCES OF ANTITUMOR AGENTS AND APOPTOSIS AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-05-14 | — | — | US | disclosed |
| WO-2000011022-A1 | ANTI-CANCER COMPOUNDS AND METHODS RELATED THERETO | STEWART JOHN M (US) | 2000-03-02 | — | — | WO | disclosed |